Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Director · CEO | August 19, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date August 19, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 65,487 |
Reported balance
After 2026-08-19 transaction · row 1
1 source rowRow 1 · 2026-08-19 · Sale · Disposed 1,500 · Balance 65,487 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $53.94 · Expires 2028-03-08 | Direct | 4,294 |
Reported balance
Holding disclosure · report date 2026-08-19 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 4,294 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $94.10 · Expires 2029-03-05 | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2026-08-19 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 5,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $90.62 · Expires 2030-02-28 | Direct | 12,000 |
Reported balance
Holding disclosure · report date 2026-08-19 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 12,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $157.13 · Expires 2031-02-23 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2026-08-19 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 20,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 20, 2026 20:17 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock | 1,500 | $237.08 | $355,620.00 |
DisclosureSEC source: 0001437749-26-028642 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,487 Read SEC document |
| May 20, 2026 Filed May 22, 2026 20:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 26 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-018246 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,987 Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:46 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,000 | $0.00 Strike: $90.62 | $0.00 |
DisclosureSEC source: 0001437749-26-017633 · rdgdoc.xml · derivative · entry 6 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 13,000 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:46 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-26-017633 · rdgdoc.xml · derivative · entry 5 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 10,000 shares Expires 2029-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:46 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 4,492 | $197.96 | $889,236.32 |
DisclosureSEC source: 0001437749-26-017633 · rdgdoc.xml · nonDerivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,013 F3 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F4 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:46 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 1,000 | $90.62 | $90,620.00 |
DisclosureSEC source: 0001437749-26-017633 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 14, 2026 Filed May 18, 2026 20:46 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 5,000 | $94.10 | $470,500.00 |
DisclosureSEC source: 0001437749-26-017633 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:10 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,853 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-26-008414 · rdgdoc.xml · derivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,294 Underlying: Common Stock · 6,147 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 20:10 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 1,853 | $53.94 | $99,950.82 |
DisclosureSEC source: 0001437749-26-008414 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:48 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $90.62 | $0.00 |
DisclosureSEC source: 0001437749-26-006645 · rdgdoc.xml · derivative · entry 5 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 18,000 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:48 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 3,585 | $171.15 | $613,572.75 |
DisclosureSEC source: 0001437749-26-006645 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,652 F2 · shares: Shares were withheld by the Company to pay tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:48 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 5,000 | $90.62 | $453,100.00 |
DisclosureSEC source: 0001437749-26-006645 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:29 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 3,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-006618 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,237 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:18 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 20,000 | $0.00 Strike: $157.13 | $0.00 |
DisclosureSEC source: 0001437749-26-005654 · rdgdoc.xml · derivative · entry 5 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-02-28 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-038931 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,171 Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 21:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 145 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037850 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,621 F1 · balance_after: Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. Read SEC document |
| December 12, 2025 Filed Dec 15, 2025 21:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 217 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-037850 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,766 Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 21:18 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 1,853 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-25-036333 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,147 Underlying: Common Stock · 8,000 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 25, 2025 Filed Nov 25, 2025 21:18 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 1,853 | $53.94 | $99,950.82 |
DisclosureSEC source: 0001437749-25-036333 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:18 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock | 1,000 | $130.33 | $130,330.00 |
DisclosureSEC source: 0001437749-25-036333 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,130 Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:23 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-25-034854 · rdgdoc.xml · derivative · entry 4 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 13,000 shares Expires 2029-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:23 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 2,480 | $132.20 | $327,856.00 |
DisclosureSEC source: 0001437749-25-034854 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,130 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:23 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 3,000 | $94.10 | $282,300.00 |
DisclosureSEC source: 0001437749-25-034854 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,610 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-25-027766 · rdgdoc.xml · derivative · entry 6 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 15,000 shares Expires 2029-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,000 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-25-027766 · rdgdoc.xml · derivative · entry 5 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 10,000 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 1,783 | $114.82 | $204,724.06 |
DisclosureSEC source: 0001437749-25-027766 · rdgdoc.xml · nonDerivative · entry 4 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,610 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F4 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 2,000 | $94.10 | $188,200.00 |
DisclosureSEC source: 0001437749-25-027766 · rdgdoc.xml · nonDerivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 1,363 | $114.82 | $156,499.66 |
DisclosureSEC source: 0001437749-25-027766 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,393 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. Read SEC document |
| August 22, 2025 Filed Aug 26, 2025 20:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 2,000 | $53.94 | $107,880.00 |
DisclosureSEC source: 0001437749-25-027766 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,756 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 21:01 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,734 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-25-021575 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,734 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 21:01 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 3,557 | $109.05 | $387,890.85 |
DisclosureSEC source: 0001437749-25-021575 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,756 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 21:01 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 4,734 | $63.96 | $302,786.64 |
DisclosureSEC source: 0001437749-25-021575 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 23:17 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006506 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,579 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:44 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 18,000 | $0.00 Strike: $90.62 | $0.00 |
DisclosureSEC source: 0001437749-25-005283 · rdgdoc.xml · derivative · entry 5 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2030-02-28 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:18 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 1,292 | $107.56 | $138,967.52 |
DisclosureSEC source: 0001437749-25-000231 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,665 F1 · shares: On 1/1/2025, 33 1/3 (or 3,029 shares) of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 1,292 shares to pay tax obligations. Read SEC document |
| January 01, 2025 Filed Jan 5, 2026 21:30 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 1,024 | $137.09 | $140,380.16 |
DisclosureSEC source: 0001437749-26-000353 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,147 F1 · shares: On 1/1/2026, 33 1/3 (or 2400 shares) of restricted stock originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. The Company withheld 1024 shares to pay tax obligations. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 21:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-000059 · rdgdoc.xml · nonDerivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,957 F2 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 21:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-000059 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · balance_after: Transaction totaled on the line below for securities of this title. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 21:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GiftCommon Stock | 885 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-000059 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · balance_after: Transaction totaled on the line below for securities of this title. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:17 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock | 3,907 | $126.54 | $494,382.01 |
DisclosureSEC source: 0001437749-24-027092 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,042 Read SEC document |
| May 17, 2024 Filed May 21, 2024 21:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-24-017859 · rdgdoc.xml · derivative · entry 4 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 12,500 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 17, 2024 Filed May 21, 2024 21:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 1,776 | $100.40 | $178,310.40 |
DisclosureSEC source: 0001437749-24-017859 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,949 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| May 17, 2024 Filed May 21, 2024 21:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 2,500 | $53.94 | $134,850.00 |
DisclosureSEC source: 0001437749-24-017859 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:26 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-24-007888 · rdgdoc.xml · derivative · entry 4 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 15,000 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:26 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 1,810 | $96.48 | $174,628.80 |
DisclosureSEC source: 0001437749-24-007888 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,225 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 21:26 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 2,500 | $53.94 | $134,850.00 |
DisclosureSEC source: 0001437749-24-007888 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 15,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-24-007001 · rdgdoc.xml · derivative · entry 4 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-03-05 F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 5, 2025; one-third (1/3) will vest on March 5, 2026; and the final one-third (1/3) will vest on March 5, 2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 22:03 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 2,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-007001 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,535 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2025, the next 33 1/3% vesting on 1/1/2026, and the final 33 1/3% vesting on 1/1/2027. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:53 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,733 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-24-005586 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,734 Underlying: Common Stock · 9,467 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 22:53 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 3,651 | $100.76 | $367,874.76 |
DisclosureSEC source: 0001437749-24-005586 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,752 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.